Latest filing published 12 Jun 2023 for GoodRx Holdings, Inc., €35k.
Filing timeline
BuySaleInsider track record
Babak Azad: trading record in brief
All filings by Babak Azad on record concern GoodRx Holdings, Inc. In total, 49 filings cover trades dated from 1 April 2021 to 8 June 2023.
The open-market record consists of 28 sales worth €10.1M, with no purchase. Besides market trades, the filings include 3 share grants and 18 option exercises.
On 12 June 2023 came the latest disclosure, a share grant for €35k in GoodRx Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Babak Azad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,055 shares@ US$5.410.3% of flowClass A Common StockSEC:0000950170-23-027563:1
- 20,401 sharesClass A Common StockSEC:0000950170-23-027563:0
- 8,089 shares@ US$5.500.4% of flowClass A Common StockSEC:0000899243-23-007774:1
- 20,402 sharesClass A Common StockSEC:0000899243-23-007774:0
- 7,055 shares@ US$4.980.3% of flowClass A Common StockSEC:0000899243-22-038249:1
- 20,401 sharesClass A Common StockSEC:0000899243-22-038249:0
- 3,770 shares@ US$40.961.2% of flowClass A Common StockSEC:0000899243-21-047893:1
- 8,430 shares@ US$42.192.7% of flowClass A Common StockSEC:0000899243-21-047893:2
- 300 shares@ US$42.680.1% of flowClass A Common StockSEC:0000899243-21-047893:3
- 12,500 shares@ US$5.944.5% of flowClass A Common StockSEC:0000899243-21-047893:0
- 5,000 shares@ US$5.941.8% of flowClass A Common StockSEC:0000899243-21-045268:0
- 11,700 shares@ US$42.173.6% of flowClass A Common StockSEC:0000899243-21-044381:1
- 800 shares@ US$43.130.3% of flowClass A Common StockSEC:0000899243-21-044381:2
- 12,500 shares@ US$5.944.4% of flowClass A Common StockSEC:0000899243-21-044381:0
- 7,500 shares@ US$40.912.3% of flowClass A Common StockSEC:0000899243-21-040104:1
- 7,500 shares@ US$5.942.7% of flowClass A Common StockSEC:0000899243-21-040104:0
- 1,801 shares@ US$40.420.5% of flowClass A Common StockSEC:0000899243-21-035755:1
- 3,400 shares@ US$41.421.0% of flowClass A Common StockSEC:0000899243-21-035755:2
- 7,299 shares@ US$42.532.2% of flowClass A Common StockSEC:0000899243-21-035755:3
- 12,500 shares@ US$5.944.3% of flowClass A Common StockSEC:0000899243-21-035755:0
- 6,250 shares@ US$33.041.5% of flowClass A Common StockSEC:0000899243-21-033166:1
- 6,250 shares@ US$5.942.2% of flowClass A Common StockSEC:0000899243-21-033166:0
- 6,250 shares@ US$31.371.4% of flowClass A Common StockSEC:0000899243-21-032504:1
- 6,250 shares@ US$5.942.2% of flowClass A Common StockSEC:0000899243-21-032504:0
- 12,500 shares@ US$32.983.0% of flowClass A Common StockSEC:0000899243-21-028120:1
25 of 49 declarations